Who owns Cytopoint?
Cytopoint is owned by Zoetis (the United States, NYSE: ZTS).[1]
Evidence: Zoetis Inc. Annual Report on Form 10-K filed 2026-02-12, SEC EDGAR, 12 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Zoetis Inc. verified
- Owner HQ
- 🇺🇸 United States, Parsippany, New Jersey
- Origin
- 🇺🇸 United States
- Founded
- 2016
- Category
- Pet & animal care › Pet supplies & services › Veterinary services
- Parent ticker
- NYSE: ZTS
- Trademark registrant
- ZOETIS SERVICES LLC (USPTO)
- Last verified
- · 2 sources
About Cytopoint
Cytopoint was the first canine monoclonal antibody, licensed in the United States in 2016 to reduce the clinical signs of atopic dermatitis, principally itching, in dogs of any age. It is given by injection rather than as a daily tablet, which distinguishes it from Apoquel in the same Zoetis dermatology franchise, and it ranked third among the company's products by revenue in 2025.
What Zoetis's annual report says about Cytopoint
Sentences about Cytopoint from Zoetis's latest annual filing[1], copied word for word.
Combined with our next three top-selling products and product lines, Cytopoint, Librela and our ceftiofur line, these five products and product lines contributed approximately 42% of our revenue.
For example, our five top-selling products and product lines, Simparica/Simparica Trio, Apoquel/Apoquel Chewable, Cytopoint, Librela and our ceftiofur line, contributed approximately 42% of our revenue in 2025, and certain issues with these top-selling products and product lines could have a more significant impact to our results of operations.
In 2025, our two top-selling products and product lines, Simparica/Simparica Trio and Apoquel/Apoquel Chewable, contributed approximately 16% and 12% of our revenue, respectively, and combined with our next three top-selling products and product lines, Cytopoint, Librela and our ceftiofur line, these five products and product lines contributed approximately 42% of our revenue.
How often Zoetis names Cytopoint in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central.
Trademark record for Cytopoint
The USPTO record for the Cytopoint mark lists ZOETIS SERVICES LLC as the owner of record (serial number 86423402). That name matches the owner named above.[2]
Ownership timeline of Cytopoint
Where Cytopoint sits in Zoetis
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Zoetis ownership tree →
See the full Zoetis brand portfolio (17) →
Other brands owned by Zoetis
Zoetis controls 17 brands on Brandtree, 17 of them in pet & animal care.
Also in pet & animal care
Other brands in veterinary services, and who owns them
Zoetis has more brands in veterinary services on Brandtree than any other owner: 17 of 45.
About the owner: Zoetis
Zoetis is a publicly listed company headquartered in Parsippany, New Jersey, United States, founded in 2012. Brandtree records 17 brands under its control, and it is listed as NYSE: ZTS.
Zoetis is the largest animal health company in the world by revenue, selling medicines, vaccines and diagnostics for pets and livestock. It was incorporated in Delaware in July 2012 out of what had been a business unit of Pfizer, and it markets directly in about 45 countries while selling in more than 100. Companion animals now dominate: its two biggest lines, the Simparica parasiticides and the Apoquel dermatology range, were 16 and 12 per cent of 2025 revenue, and it left the medicated feed additive business entirely in 2024.
🇺🇸 Cytopoint and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Cytopoint is not one of them.
- 4health — Tractor Supply 🇺🇸
- Advantage — Elanco 🇺🇸
- American Journey — Chewy 🇺🇸
- Aqueon — Central Garden & Pet 🇺🇸
- Aureomycin — Phibro 🇺🇸
- BARK — BARK 🇺🇸
Frequently asked questions
Who is the parent company of Cytopoint?
The parent company of Cytopoint is Zoetis, a publicly listed company headquartered in the United States.
Is Cytopoint American?
Yes. Cytopoint originated in the United States in 2016 and its owner, Zoetis, is also headquartered in the United States.
Is Cytopoint still owned by Zoetis?
Yes. As of 9 October 2026, Cytopoint is still owned by Zoetis. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Zoetis Inc. Annual Report on Form 10-K filed 2026-02-12 — SEC EDGAR, SEC Form 10-K, published 12 February 2026; retrieved 25 September 2026.
- [2] USPTO: CYTOPOINT, serial 86423402 — United States Patent and Trademark Office, Trademark registry; retrieved 27 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.